Treatment of Post-Transplantation Lymphoproliferative Disorders After Kidney Transplant With Rituximab and Conversion to M-TOR Inhibitor. Colomb Med 2016, 47 (4), 196-202. https://doi.org/10.25100/cm.v47i4.1989.